Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%
Shares of EI Du Pont de Nemours Under Pressure, Down 1.1%

Print Share

Jan 16, 2013 (Market movers via COMTEX) -- One of today's stocks on the move is EI Du Pont de Nemours (NYSE:DD), down 1.1% to $45.73. The Dow is down 0.3% to 13,498 and the S&P is currently trading fractionally lower to 1,470.

In the past 52 weeks, shares of EI Du Pont de Nemours have traded between a low of $41.67 and a high of $57.50 and are now at $45.73, which is 10% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has slid 0.2%.

There is potential upside of 8.7% for shares of EI Du Pont de Nemours based on a current price of $45.73 and an average consensus analyst price target of $49.69. EI Du Pont de Nemours shares should encounter resistance at the 200-day moving average (MA) of $48.58 and support at the 50-day MA of $44.12.

E. I. du Pont de Nemours and Company is a global chemical and life sciences company, with businesses that include agriculture and industrial biotechnology, chemistry, biology, materials science and manufacturing. The Company operates globally and offers a wide range of products and services for markets including agriculture and food, building and construction, electronics and communications.

---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.

Copyright, Comtex News Network, Inc. 2013

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.